Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases

Inflammatory Bowel Diseases

Volumn 22, Issue 2, 2016, Pages 433-449

  Ochoa Cortes, Fernando ^a   Turco, Fabio ^a,b   Linan Rico, Andromeda ^a   Soghomonyan, Suren ^a   Whitaker, Emmett ^a   Wehner, Sven ^c   Cuomo, Rosario ^b   Christofi, Fievos L ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

calcium signaling; enteric glial cells; enteric nervous system; GI infection; gliotransmission; human enteric glial cell; inflammatory bowel diseases; motility; neuroglial communication; postoperative ileus; purinergic signaling; reactive hEGC phenotype; tipartite synapse

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALCIUM ION; GAP JUNCTION PROTEIN; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROBIOTIC AGENT; PROTEIN S100B; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ARTICLE; BACTERIAL INFECTION; CALCIUM SIGNALING; CELL COMMUNICATION; CELL FUNCTION; CELL INTERACTION; CELL MOTILITY; CELL STRUCTURE; DIGESTIVE SYSTEM FUNCTION DISORDER; ESCHERICHIA COLI; GAP JUNCTION; GASTRIC DYSMOTILITY; GASTROENTEROLOGY; GASTROINTESTINAL DISEASE; GLIA CELL; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INTESTINE INFECTION; INTESTINE MOTILITY; IRRITABLE COLON; MICROENVIRONMENT; MOUSE MODEL; NERVOUS SYSTEM DEVELOPMENT; NEUROGASTROENTEROLOGY; NEUROIMAGING; NEUROLOGY; NONHUMAN; POSTOPERATIVE ILEUS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TARGET CELL; VIRUS INFECTION; CELL PROTECTION; CYTOLOGY; GLIA; INFLAMMATORY BOWEL DISEASES; INTESTINE INNERVATION; PROGNOSIS;

CELL COMMUNICATION; CYTOPROTECTION; ENTERIC NERVOUS SYSTEM; GASTROENTEROLOGY; HUMANS; INFLAMMATORY BOWEL DISEASES; NEUROGLIA; PROGNOSIS; SIGNAL TRANSDUCTION;

EID: 84955580382     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000667     Document Type: Article

References (182)

1. Gabella G. Fine structure of the myenteric plexus in the guinea-pig ileum. J Anat. 1972;111:69-97.
2. Gulbransen BD, Sharkey KA. Novel functional roles for enteric glia in the gastrointestinal tract. Nat Rev Gastroenterol Hepatol. 2012;9:625-632.
3. Sharkey KA. Emerging roles for enteric glia in gastrointestinal disorders. J Clin Invest. 2015;125:918-925.
4. Yu YB, Li YQ. Enteric glial cells and their role in the intestinal epithelial barrier. World J Gastroenterol. 2014;20:11273-11280.
5. Goyal RK, Hirano I. The enteric nervous system. N Engl J Med. 1996; 34:1106-1115.
6. Bozarov A, Wang YZ, Yu JG, et al. Activation of adenosine low-affinity A3 receptors inhibits the enteric short interplexus neural circuit triggered by histamine. Am J Physiol Gastrointest Liver Physiol. 2009;297: G1147-G1162.
7. Christofi FL. Purinergic receptors and gastrointestinal secretomotor function. Purinergic Signal. 2008;4:213-236.
8. Furness JB. The enteric nervous system: normal functions and enteric neuropathies. Neurogastroenterol Motil. 2008;20:32-38.
9. Hoff S, Zeller F, Von Weyhern CW, et al. Quantitative assessment of glial cells in the human and guinea pig enteric nervous system with an anti-Sox8/9/10 antibody. J Comp Neurol. 2008;509:356-371.
10. Boesmans W, Lasrado R, Vanden Berghe P, et al. Heterogeneity and phenotypic plasticity of glial cells in the mammalian enteric nervous system. Glia. 2015;63:229-241.
11. Gershon MD, Rothman TP. Enteric glia. Glia. 1991;4:195-204.
12. Rühl A. Glial cells in the gut. Neurogastroenterol Motil. 2005;17: 777-790.
13. Bush TG, Savidge TC, Freeman TC, et al. Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell. 1998;93: 189-201.
14. Cirillo C, Sarnelli G, Turco F, et al. Proinflammatory stimuli activates human-derived enteroglial cells and induces autocrine nitric oxide production. Neurogastroenterol Motil. 2011;23:e372-e382.
15. Rolhion N, Darfeuille-Michaud A. Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:1277-1283.
16. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122:44-54.
17. Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet. 1991; 338:771-774.
18. Turco F, Sarnelli G, Cirillo C, et al. Enteroglial-derived S100B protein integrates bacteria-induced Toll-like receptor signalling in human enteric glial cells. Gut. 2014;63:105-115.
19. Glasser AL, Boudeau J, Barnich N, et al. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun. 2001;69:5529-5537.
20. Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011;140:1720-1728.
21. Nguyen HT, Dalmasso G, Müller S, et al. Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy. Gastroenterology. 2014; 146:508-519.
22. MacEachern SJ, Patel BA, Keenan CM, et al. Inhibiting inducible nitric oxide synthase in enteric glia restores electrogenic ion transport in mice with colitis. Gastroenterology. 2015;149:445-455.
23. Xie J, Méndez JD, Méndez-Valenzuela V, et al. Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell Signal. 2013;25:2185-2197.
24. Cornet A, Savidge TC, Cabarrocas J, et al. Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease? Proc Natl Acad Sci USA. 2001;98:13306-13311.
25. Cirillo C, Sarnelli G, Esposito G, et al. Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein. Neurogastroenterol Motil. 2009;21:1209-e112.
26. Cirillo C, Sarnelli G, Mango A, et al. Enteric glia stimulates inflammation-induced responses in human intestine and interacts with immune cells via S100B protein. Gastroenterology. 2009;136:A271-A272.
27. Von Boyen GB, Schulte N, Pflüger C, et al. Distribution of enteric glia and GDNF during gut inflammation. BMC Gastroenterol. 2011;11:3.
28. von Boyen GB, Steinkamp M, Reinshagen M, et al. Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia. Gut. 2004;53:222-228.
29. Cirillo C, Sarnelli G, Esposito G, et al. S100B protein in the gut: the evidence for enteroglial-sustained intestinal inflammation. World J Gas-troenterol. 2011;17:1261-1266.
30. Neunlist M, Rolli-Derkinderen M, Latorre R, et al. Enteric glial cells: recent developments and future directions. Gastroenterology. 2014;147: 1230-1237.
31. Esposito G, Capoccia E, Turco F, et al. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-a activation. Gut. 2014;63:1300-1312.
32. Valès S, Biraud M, Marionneau-Lambot S, et al. Enteric glial cells activate colon cancer stem cells to promote tumorigenesis. FASEB J. 2015;1:1000.2.
33. Bassotti G, Battaglia E, Bellone G, et al. Interstitial cells of Cajal, enteric nerves, and glial cells in colonic diverticular disease. J Clin Pathol. 2005;58:973-977.
34. Wedel T, Büsing V, Heinrichs G, et al. Diverticular disease is associated with an enteric neuropathy as revealed by morphometric analysis. Neuro-gastroenterol Motil. 2010;22:407-414, e93-94.
35. Bassotti G, Villanacci V, Cathomas G, et al. Enteric neuropathology of the terminal ileum in patients with intractable slow-transit constipation. Hum Pathol. 2006;37:1252-1258.
36. Iantorno G, Bassotti G, Kogan Z, et al. The enteric nervous system in chagasic and idiopathic megacolon. Am J Surg Pathol. 2007;31: 460-468.
37. Da Silveira AB, Freitas MA, de Oliveira EC, et al. Glial fibrillary acidic protein and S-100 colocalization in the enteroglial cells in dilated and nondilated portions of colon from chagasic patients. Hum Pathol. 2009; 40:244-251.
38. Erlich RB, Kahn SA, Lima FR, et al. STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia. 2007;55:1690-1698.
39. Lima FR, Arantes CP, Muras AG, et al. Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation. J Neurochem. 2007;103:2164-2176.
40. Braga CA, Follmer C, Palhano FL, et al. The anti-Parkinsonian drug selegiline delays the nucleation phase of a-synuclein aggregation leading to the formation of nontoxic species. J Mol Biol. 2011;405:254-273.
41. Kujala P, Raymond CR, Romeijn M, et al. Prion uptake in the gut: identification of the first uptake and replication sites. PLoS Pathog. 2011;7:e1002449.
42. Seelig DM, Mason GL, Telling GC, et al. Chronic wasting disease prion trafficking via the autonomic nervous system. Am J Pathol. 2011;179: 1319-1328.
43. Cronier S, Carimalo J, Schaeffer B, et al. Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death. FASEB J. 2012;26:3854-3861.
44. Fonseca AC, Romão L, Amaral RF, et al. Microglial stress inducible protein 1 promotes proliferation and migration in human glioblastoma cells. Neuroscience. 2012;200:130-141.
45. Devos D, Lebouvier T, Lardeux B, et al. Colonic inflammation in Parkinson's disease. Neurobiol Dis. 2013;50:42-48.
46. Shannon KM, Keshavarzian A, Dodiya HB, et al. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases. Mov Disord. 2012;27:716-719.
47. Clairembault T, Kamphuis W, Leclair-Visonneau L, et al. Enteric GFAP expression and phosphorylation in Parkinson's disease. J Neurochem. 2014;130:805-815.
48. Blandini F, Balestra B, Levandis G, et al. Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's disease. Neurosci Lett. 2009;467:203-207.
49. Cersosimo MG, Benarroch EE. Pathological correlates of gastrointestinal dysfunction in Parkinson's disease. Neurobiol Dis. 2012;46:559-564.
50. Sigge W, Wedel T, Kühnel W, et al. Morphologic alterations of the enteric nervous system and deficiency of non-adrenergic non-cholinergic inhibitory innervation in neonatal necrotizing enterocolitis. Eur J Pediatr Surg. 1998;8:87-94.
51. Wedel T, Krammer HJ, Kühnel W, et al. Alterations of the enteric nervous system in neonatal necrotizing enterocolitis revealed by whole-mount immunohistochemistry. Pediatr Pathol Lab Med. 1998; 18:57-70.
52. Sokol H, Polin V, Lavergne-Slove A, et al. Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease. Gut. 2009; 58:1218-1225.
53. Coelho-Aguiar Jde M, Bon-Frauches AC, Gomes AL, et al. The enteric glia: identity and functions. Glia. 2015;63:921-935.
54. Steinkamp M, Gundel H, Schulte N, et al. GDNF protects enteric glia from apoptosis: evidence for an autocrine loop. BMC Gastroenterol. 2012;12:6.
55. Steinkamp M, Schulte N, Spaniol U, et al. Brain derived neurotrophic factor inhibits apoptosis in enteric glia during gut inflammation. Med Sci Monit. 2012;18:BR117-BR122.
56. Nasser Y, Fernandez E, Keenan CM, et al. Role of enteric glia in intestinal physiology: effects of the gliotoxin fluorocitrate on motor and secretory function. Am J Physiol Gastrointest Liver Physiol. 2006;291: G912-G927.
57. Aubé AC, Cabarrocas J, Bauer J, et al. Changes in enteric neurone phenotype and intestinal functions in a transgenic mouse model of enteric glia disruption. Gut. 2006;55:630-637.
58. Linan Rico A, Grants I, Needleman BJ, et al. Gliomodulation of neuronal and motor behavior in the human GI tract. Gastroenterology. 2015;148:S-18.
59. 2+ responses in enteric glia are mediated by connexin-43 hemichannels and modulate colonic transit in mice. Gastroenterology. 2014;146:497-507.
60. 2+ transients in myenteric glial cells during the colonic migrating motor complex in the isolated murine large intestine. J Physiol. 2012;590:335-350.
61. 2+ waves in human enteric glial cells. Gastroenterology. 2015;148:S-79.
62. Gulbransen BD, Sharkey KA. Purinergic neuron-to-glia signaling in the enteric nervous system. Gastroenterology. 2009;136:1349-1358.
63. Boesmans W, Martens MA, Weltens N, et al. Imaging neuron-glia interactions in the enteric nervous system. Front Cell Neurosci. 2013;7:183.
64. Gulbransen BD, Bashashati M, Hirota SA, et al. Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat Med. 2012;18:600-604.
65. Gabella G. Ultrastructure of the nerve plexuses of the mammalian intestine: the enteric glial cells Neuroscience. 1981:6:425-436.
66. Okamoto T, Barton MJ, Hennig GW, et al. Extensive projections of myenteric serotonergic neurons suggest they comprose the central processing unit in th colon. Neurogastroenterolo Motil. 2014;26:556-570.
67. Garcia-Abreu J, Silva LC, Tovar FF, et al. Compartmental distribution of sulfated glycosaminoglycans in lateral and medial midbrain astroglial cultures. Glia. 1996;17:339-344.
68. Fróes MM, Correia AH, Garcia-Abreu J, et al. Gap-junctional coupling between neurons and astrocytes in primary central nervous system cultures. Proc Natl Acad Sci USA. 1999;96:7541-7546.
69. Faria J, Romão L, Martins S, et al. Interactive properties of human glioblastoma cells with brain neurons in culture and neuronal modulation of glial laminin organization. Differentiation. 2006;74:562-572.
70. Izmiryan A, Cheraud Y, Khanamiryan L, et al. Different expression of synemin isoforms in glia and neurons during nervous system development. Glia. 2006;54:204-213.
71. Romão LF, Mendes FA, Feitosa NM, et al. Connective tissue growth factor (CTGF/CCN2) is negatively regulated during neuron-glioblastoma interaction. PLoS One. 2013;8:e55605.
72. Araque A, Parpura V, Sanzgiri RP, et al. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci. 1999;22:208-215.
73. Romão LF, Sousa Vde O, Neto VM, et al. Glutamate activates GFAP gene promoter from cultured astrocytes through TGF-beta1 pathways. JNeurochem. 2008;106:746-756.
74. Bezzi P, Volterra A. A neuron-glia signalling network in the active brain. Curr Opin Neurobiol. 2001;11:387-394.
75. Diniz LP, Almeida JC, Tortelli V, et al. Astrocyte-induced synaptogen-esis is mediated by transforming growth factor P signaling through modulation of D-serine levels in cerebral cortex neurons. J Biol Chem. 2012; 287:41432-41445.
76. Gomes FC, Garcia-Abreu J, Galou M, et al. Neurons induce GFAP gene promoter of cultured astrocytes from transgenic mice. Glia. 1999;26:97-108.
77. Gomes FC, Maia CG, de Menezes JR, et al. Cerebellar astrocytes treated by thyroid hormone modulate neuronal proliferation. Glia. 1999;25:247-255.
78. 2+ dynamics and consequent glutamate release from rat astrocytes. Glia. 2008;56:821-835.
79. 2+ elevations in astrocytes in hippocampal slices. J Neurosci. 2002;22:2443-2450.
80. Perea G, Araque A. Properties of synaptically evoked astrocyte calcium signal reveal synaptic information processing by astrocytes. J Neurosci. 2005;25:2192-2203.
81. Erratum in: J Neurosci. 2005;25:3022.
82. Bergami M, Santi S, Formaggio E, et al. Uptake and recycling of pro-BDNF for transmitter-induced secretion by cortical astrocytes. J Cell Biol. 2008;183:213-221.
83. Blum AE, Joseph SM, Przybylski RJ, et al. Rho-family GTPases modulate Ca(2+)-dependent ATP release from astrocytes. Am J Physiol Cell Physiol. 2008;295:C231-C241.
84. Fujita T, Tozaki-Saitoh H, Inoue K. P2Y1 receptor signaling enhances neuroprotection by astrocytes against oxidative stress via IL-6 release in hippocampal cultures. Glia. 2009;57:244-257.
85. Zhuang Z, Yang B, Theus MH, et al. EphrinBs regulate D-serine synthesis and release in astrocytes. J Neurosci. 2010;30:16015-16024.
86. Kang N, Peng H, Yu Y, et al. Astrocytes release D-serine by a large vesicle. Neuroscience. 2013;240:243-257.
87. Vijayaraghavan S. Glial-neuronal interactions-implications for plasticity and drug addiction. AAPS J. 2009;11:123-132.
88. Fujikawa Y, Tominaga K, Tanaka F, et al. Enteric glial cells are associated with stress-induced colonic hyper-contraction in maternally separated rats. Neurogastroenterol Motil. 2015;27:1010-1023.
89. Kabouridis PS, Lasrado R, McCallum S, et al. Microbiota controls the homeostasis of glial cells in the gut lamina propria. Neuron. 2015;85: 289-295.
90. Brun P, Giron MC, Qesari M, et al. Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system. Gastroenterology. 2013;145:1323-1333.
91. Barajon I, Serrao G, Arnaboldi F, et al. Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J Histochem Cytochem. 2009;57:1013-1023.
92. Stoffels B, Hupa KJ, Snoek SA, et al. Postoperative ileus involves interleukin-1 receptor signaling in enteric glia. Gastroenterology. 2014;146:176-187.
93. Li YX, Schaffner AE, Walton MK, et al. Astrocytes regulate developmental changes in the chloride ion gradient of embryonic rat ventral spinal cord neurons in culture. J Physiol. 1998;509:847-858.
94. Cotrina ML, Nedergaard M. Intracellular calcium control mechanisms in glia. In: Kettenman H, Ransom BR, eds. Neuroglia. 2nd ed. Oxford, NY: Oxford University Press; 2004:230-242.
95. Codazzi F, Teruel MN, Meyer T. Control of astrocyte Ca(2+) oscillations and waves by oscillating translocation and activation of protein kinase. Curr Biol. 2001;11:1089-1097.
96. Pasti L, Volterra A, Pozzan T, et al. Intracellular calcium oscillations in astrocytes: a highly plastic, bidirectional form of communication between neurons and astrocytes in situ. J Neurosci. 1997;17:7817-7830.
97. Harris-White ME, Zanotti SA, Frautschy SA, et al. Spiral intercellular calcium waves in hippocampal slice cultures. J Neurophysiol. 1998;79: 1045-1052.
98. Arcuino G, Lin JH, Takano T, et al. Intercellular calcium signaling mediated by point-source burst release of ATP. Proc Natl Acad Sci USA. 2002;99:9840-9845.
99. Cornell-Bell AH, Finkbeiner SM, Cooper MS, et al. Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. Science. 1990;247:470-473.
100. John GR, Scemes E, Suadicani SO, et al. IL-1beta differentially regulates calcium wave propagation between primary human fetal astrocytes via pathways involving P2 receptors and gap junction channels. Proc Natl Acad Sci USA. 1999;96:11613-11618.
101. Cotrina ML, Lin JH, Alves-Rodrigues A, et al. Connexins regulate calcium signaling by controlling ATP release. Proc Natl Acad Sci USA. 1998;95:15735-15740.
102. Volterra A, Liaudet N, Savtchouk I. Astrocyte Ca? signalling: an unexpected complexity. Nat Rev Neurosci. 2014;15:327-335.
103. Sibille J, Zapata J, Teillon J, et al. Astroglial calcium signaling displays short-term plasticity and adjusts synaptic efficacy. Front Cell Neurosci. 2015;9:189.
104. Serrano A, Haddjeri N, Lacaille JC, et al. GABAergic network activation of glial cells underlies hippocampal heterosynaptic depression. J Neurosci. 2006;26:5370-5382.
105. Henneberger C, Papouin T, Oliet SH, et al. Long-term potentiation depends on release of D-serine from astrocytes. Nature. 2010;463:232-236.
106. Panatier A, Vallée J, Haber M, et al. Astrocytes are endogenous regulators of basal transmission at central synapses. Cell. 2011;146: 785-798.
107. Navarrete M, Perea G, Fernandez de Sevilla D, et al. Astrocytes mediate in vivo cholinergic-induced synaptic plasticity. PLoS Biol. 2012;10: e1001259.
108. Benedetti B, Matyash V, Kettenmann H. Astrocytes control GABAergic inhibition of neurons in the mouse barrel cortex. J Physiol. 2011;589: 1159-1172.
109. Andersson M, Hanse E. Astrocytes impose postburst depression of release probability at hippocampal glutamate synapses. J Neurosci. 2010;30:5776-5780.
110. Navarrete M, Araque A. Endocannabinoids mediate neuron-astrocyte communication. Neuron. 2008;57:883-893.
111. 2+-permeable AMPA receptors in Bergmann glia. Science. 2001;292: 926-929.
112. Saab AS, Neumeyer A, Jahn HM, et al. Bergmann glial AMPA receptors are required for fine motor coordination. Science. 2012;337:749-753.
113. Lee HU, Yamazaki Y, Tanaka KF, et al. Increased astrocytic ATP release results in enhanced excitability of the hippocampus. Glia. 2013;61:210-224.
114. Bernardinelli Y, Randall J, Janett E, et al. Activity-dependent structural plasticity of perisynaptic astrocytic domains promotes excitatory synapse stability. Curr Biol. 2014;24:1679-1688.
115. Pannasch U, Freche D, Dallérac G, et al. Connexin 30 sets synaptic strength by controlling astroglial synapse invasion. Nat Neurosci. 2014;17:549-558.
116. +. Sci Signal. 2012; 5:ra26.
117. Alvarez-Maubecin V, Garcia-Hernandez F, Williams JT, et al. Functional coupling between neurons and glia. J Neurosci. 2000;20:4091-4098.
118. Accorsi-Mendonça D, Zoccal DB, Bonagamba LG, et al. Glial cells modulate the synaptic transmission of NTS neurons sending projections to ventral medulla of Wistar rats. Physiol Rep. 2013;1:e00080.
119. López-Hidalgo M, Salgado-Puga K, Alvarado-Martínez R, et al. Nicotine uses neuron-glia communication to enhance hippocampal synaptic transmission and long-term memory. PLoS One. 2012;7:e49998.
120. Haydon PG, Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev. 2006;86:1009-1031.
121. Andersson M, Blomstrand F, Hanse E. Astrocytes play a critical role in transient heterosynaptic depression in the rat hippocampal CA1 region. J Physiol. 2007;585:843-852.
122. Straub SV, Nelson MT. Astrocytic calcium signaling: the information currency coupling neuronal activity to the cerebral microcirculation. Trends Cardiovasc Med. 2007;17:183-190.
123. Tian GF, Azmi H, Takano T, et al. An astrocytic basis of epilepsy. Nat Med. 2005;11:973-981.
124. Parpura V, Haydon PG. Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. Proc Natl Acad Sci USA. 2000;97:8629-8634.
125. Fiacco TA, McCarthy KD. Astrocyte calcium elevations: properties, propagation, and effects on brain signaling. Glia. 2006;54:676-690.
126. Kang J, Jiang L, Goldman SA, et al. Astrocyte-mediated potentiation of inhibitory synaptic transmission. Nat Neurosci. 1998;1:683-692.
127. Liu QS, Xu Q, Kang J, et al. Astrocyte activation of presynaptic metab-otropic glutamate receptors modulates hippocampal inhibitory synaptic transmission. Neuron Glia Biol. 2004;1:307-316.
128. Zonta M, Angulo MC, Gobbo S, et al. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci. 2003;6:43-50.
129. Newman EA. Glial cell inhibition of neurons by release of ATP. J Neurosci. 2003;23:1659-1666.
130. Navarrete M, Perea G, Maglio L, et al. Astrocyte calcium signal and gliotransmission in human brain tissue. Cereb Cortex. 2013;23: 1240-1246.
131. Liñán-Rico A, Wunderlich JE, Enneking JT, et al. Neuropharmacology of purinergic receptors in human submucous plexus: Involvement of P2X1, P2X2, P2X3 channels, P2Y and A3 metabotropic receptors in neurotransmission. Neuropharmacology. 2015;95:83-99.
132. Bennett MV, Garré JM, Orellana JA, et al. Connexin and pannexin hemichannels in inflammatory responses of glia and neurons. Brain Res. 2012;1487:3-15.
133. Karpuk N, Burkovetskaya M, Fritz T, et al. Neuroinflammation leads to region-dependent alterations in astrocyte gap junction communication and hemichannel activity. J Neurosci. 2011;31:414-425.
134. Bennett MV, Barrio LC, Bargiello TA, et al. Gap junctions: new tools, new answers, new questions. Neuron. 1991;6:305-320.
135. Beyer EC, Paul DL, Goodenough DA. Connexin family of gap junction proteins. J Membr Biol. 1990;116:187-194.
136. Dermietzel R, Hwang TK, Spray DS. The gap junction family: structure, function and chemistry. Anat Embryol (Berl). 1990;182:517-528.
137. Musil LS, Goodenough DA. Gap junctional intercellular communication and the regulation of connexin expression and function. Curr Opin Cell Biol. 1990;2:875-880.
138. Blackburn JP, Peters NS, Yeh HI, et al. Upregulation of connexin43 gap junctions during early stages of human coronary atherosclerosis. Arte-rioscler Thromb Vasc Biol. 1995;15:1219-1228.
139. Lecca D, Ceruti S, Fumagalli M, et al. Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death. Purinergic Signal. 2012;8:539-557.
140. Fields RD, Burnstock G. Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci. 2006;7:423-436.
141. Pearson T, Currie AJ, Etherington LA, et al. Plasticity of purine release during cerebral ischemia: clinical implications? J Cell Mol Med. 2003;7: 362-375.
142. Di Virgilio F, Ceruti S, Bramanti P, et al. Purinergic signalling in inflammation of the central nervous system. Trends Neurosci. 2009; 32:79-87.
143. Chakraborty S, Kaushik DK, Gupta M, et al. Inflammasome signaling at the heart of central nervous system pathology. J Neurosci Res. 2010;88: 1615-1631.
144. Li H, Ambade A, Re F. Cutting edge: necrosis activates the NLRP3 inflammasome. J Immunol. 2009;183:1528-1532.
145. Minkiewicz J, de Rivero Vaccari JP, Keane RW. Human astrocytes express a novel NLRP2 inflammasome. Glia. 2013;61:1113-1121.
146. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007;81:1-5.
147. Hansen JD, Vojtech LN, Laing KJ. Sensing disease and danger: a survey of vertebrate PRRs and their origins. Dev Comp Immunol. 2011;35:886-897.
148. Cahill CM, Rogers JT. Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IkappaB kinase alpha pathway targeting activator protein-1. J Biol Chem. 2008; 283:25900-25912.
149. Ikejima T, Okusawa S, Ghezzi P, et al. Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J Infect Dis. 1990;162:215-223.
150. Dunn SL, Young EA, Hall MD, et al. Activation of astrocyte intracel-lular signaling pathways by interleukin-1 in rat primary striatal cultures. Glia. 2002;37:31-42.
151. Tschopp J. Mitochondria: Sovereign of inflammation? Eur J Immunol. 2011;41:1196-1202.
152. Gross O, Thomas CJ, Guarda G, et al. The inflammasome: an integrated view. Immunol Rev. 2011;243:136-151.
153. Dupin E, Creuzet S, Le Douarin NM. The contribution of the neural crest to the vertebrate body. Adv Exp Med Biol. 2006;589:96-119.
154. Joseph NM, He S, Quintana E, et al. Enteric glia are multipotent in culture but primarily form glia in the adult rodent gut. J Clin Invest. 2011;121:3398-3411.
155. Laranjeira C, Sandgren K, Kessaris N, et al. Glial cells in the mouse enteric nervous system can undergo neurogenesis in response to injury. J Clin Invest. 2011;121:3412-3424.
156. Gershon MD. Behind an enteric neuron there may lie a glial cell. J Clin Invest. 2011;121:3386-3389.
157. Bassotti G, Villanacci V, Nascimbeni R, et al. Increase of colonic mast cells in obstructed defecation and their relationship with enteric glia. Dig Dis Sci. 2012;57:65-71.
158. Flamant M, Aubert P, Rolli-Derkinderen M, et al. Enteric glia protect against Shigella flexneri invasion in intestinal epithelial cells: a role for S-nitrosoglutathione. Gut. 2011;60:473-484.
159. Sartor RB, Mazmanian SK. Intestinal Microbes in inflammatory bowel diseases. Am J Gastroenterol. 2012;1:15-21.
160. Sofroniew MV. Astrocyte barriers to neurotoxic inflammation. Nat Rev Neurosci. 2015;16:249-263.
161. Zamanian JL, Xu L, Foo LC, et al. Genomic analysis of reactive astro-gliosis. J Neurosci. 2012;32:6391-6410.
162. Hamby ME, Coppola G, Ao Y, et al. Inflammatory mediators alter the astrocyte transcriptome and calcium signaling elicited by multiple G-protein-coupled receptors. J Neurosci. 2012;32:14489-14510.
163. Ortinski PI, Dong J, Mungenast A, et al. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci. 2010;13: 584-591.
164. Selgrad M, De Giorgio R, Fini L, et al. JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. Gut. 2009; 58:25-32.
165. Galligan JJ. HIV, Opiates, and enteric neuron dysfunction. Neurogas-troenterol Motil. 2015;27:449-454.
166. Fagbemi AO, Torrente F, Puleston J, et al. Enteric neural disruption in necrotizing enterocolitis occurs in association with myenteric glial cell CCL20 expression. J Pediatr Gastroenterol Nutr. 2013;57:788-793.
167. Savidge TC, Newman P, Pothoulakis C, et al. Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione. Gastroenterology. 2007;132:1344-1358.
168. Neunlist M, Aubert P, Bonnaud S, et al. Enteric glia inhibit intestinal epithelial cell proliferation partly through a TGF-beta1-dependent pathway. Am J Physiol Gastrointest Liver Physiol. 2007;292: G231-G241.
169. Bach-Ngohou K, Mahé MM, Aubert P, et al. Enteric glia modulate epithelial cell proliferation and differentiation through 15-deoxy-12, 14-prostaglandin J2. J Physiol. 2010;588:2533-2544.
170. Van Landeghem L, Mahé MM, Teusan R, et al. Regulation of intestinal epithelial cells transcriptome by enteric glial cells: impact on intestinal epithelial barrier functions. BMC Genomics. 2009;10:507.
171. Bohórquez DV, Samsa LA, Roholt A, et al. An enteroendocrine cell-enteric glia connection revealed by 3D electron microscopy. PLoS One. 2014;9:e89881.
172. Mwangi S, Anitha M, Mallikarjun C, et al. Glial cell line-derived neuro-trophic factor increases beta-cell mass and improves glucose tolerance. Gastroenterology. 2008;134:727-737.
173. Costantini TW, Bansal V, Krzyzaniak M, et al. Vagal nerve stimulation protects against burn-induced intestinal injury through activation of enteric glia cells. Am J Physiol Gastrointest Liver Physiol. 2010;299: G1308-G1318.
174. Hu S, Zhao ZK, Liu R, et al. Electroacupuncture activates enteric glial cells and protects the gut barrier in hemorrhaged rats. World J Gastro-enterol. 2015;21:1468-1478.
175. Esposito G, Capoccia E, Sarnelli G, et al. The antiprotozoal drug pent-amidine ameliorates experimentally induced acute colitis in mice. J Neuroinflammation. 2012;9:277.
176. Sharkey KA, Nasser Y, Ruhl A. Enteric glia. Gut. 2004;53:1390.
177. Alhouayek M, Muccioli GG. The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity. Trends Mol Med. 2012;18:615-625.
178. McKernan DP, Finn DP. An apPEAling new therapeutic for ulcerative colitis? Gut. 2014;63:1207-1208.
179. Rühl A, Trotter J, Stremmel W. Isolation of enteric glia and establishment of transformed enteroglial cell lines from the myenteric plexus of adult rat. Neurogastroenterol Motil. 2001;13:95-106.
180. Soret R, Coquenlorge S, Cossais F, et al. Characterization of human, mouse, and rat cultures of enteric glial cells and their effect on intestinal epithelial cells. Neurogastroenterol Motil. 2013;25:e755-e764.
181. Boesmans W, Rocha NP, Reis HJ, et al. The astrocyte marker Aldh1L1 does not reliably label enteric glial cells. Neurosci Lett. 2014;566:102-105.
182. Ochoa-Cortes F, Liñán-Rico A, Jacobson KA, et al. Potential for developing purinergic drugs for gastrointestinal diseases. Inflamm Bowel Dis. 2014;20:1259-1287.